Hennion & Walsh Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Sell
14,825
-1,179
-7% -$121K 0.04% 475
2026
Q1
$1.75M Sell
16,004
-10,691
-40% -$1.02M 0.06% 384
2025
Q4
$2.16M Sell
26,695
-500
-2% -$43K 0.07% 337
2025
Q3
$2.38M Buy
27,195
+1,840
+7% +$164K 0.09% 303
2025
Q2
$2.11M Buy
25,355
+1,561
+7% +$130K 0.09% 306
2025
Q1
$2M Buy
23,794
+3,852
+19% +$358K 0.09% 275
2024
Q4
$1.84M Buy
19,942
+2,094
+12% +$201K 0.08% 311
2024
Q3
$1.66M Buy
17,848
+7,559
+73% +$655K 0.08% 327
2024
Q2
$847K Buy
10,289
+3,947
+62% +$290K 0.04% 465
2024
Q1
$421K Buy
6,342
+993
+19% +$61.3K 0.02% 610
2023
Q4
$304K Sell
5,349
-1,348
-20% -$70.6K 0.02% 677
2023
Q3
$365K Sell
6,697
-264
-4% -$15.6K 0.02% 608
2023
Q2
$468K Sell
6,961
-260
-4% -$15.9K 0.03% 524
2023
Q1
$372K Sell
7,221
-250
-3% -$12.1K 0.02% 586
2022
Q4
$344K Sell
7,471
-75
-1% -$3.51K 0.02% 589
2022
Q3
$382K Buy
7,546
+146
+2% +$7.3K 0.03% 541
2022
Q2
$337K Buy
7,400
+2,093
+39% +$93.6K 0.02% 598
2022
Q1
$247K Buy
+5,307
New +$237K 0.01% 702

Other funds holding LMAT

Hennion & Walsh Asset Management's LMAT Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its LeMaitre Vascular (LMAT) stake by 7.4% in Q2 2026, selling an estimated $121K and leaving 14,825 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #475.

Hennion & Walsh Asset Management first reported a position in LMAT in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.38M in Q3 2025. 63 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Hennion & Walsh Asset Management held 14,825 shares of LeMaitre Vascular worth $1.42M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 1,179 LeMaitre Vascular shares in Q2 2026, an estimated $121K.
  • LeMaitre Vascular made up 0.04% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #475 holding.
  • Hennion & Walsh Asset Management first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 18 quarters since.
  • Hennion & Walsh Asset Management's LeMaitre Vascular position peaked at $2.38M in Q3 2025.
  • 63 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.